Amundi

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1330387 Paris, I0

Position in ARWR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,112,611

+$27,839 QoQ

Shares Held

13,650

-21.1% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#235

of 497 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,056,148 across 70 Biotechnology names. ARWR ranks #25 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,546,509	$768,197,412
2	REGN	Regeneron Pharmaceuticals, Inc.	1,013,540	$631,982,729
3	RPRX	Royalty Pharma plc	3,723,864	$208,797,052
4	ALNY	Alnylam Pharmaceuticals, Inc.	617,471	$185,877,294
5	INCY	Incyte Corp	1,181,498	$133,934,612
6	TECH	BIO-TECHNE Corp	1,827,241	$129,094,576
7	MRNA	Moderna, Inc.	888,779	$62,241,193
8	ARGX	Argenx SE	65,122	$60,418,237

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,112,611	13,650	-21.1%	Shares	Defined	2026-08-11
2026-03-31	$1,084,772	17,301	-34.4%	Shares	Defined	2026-05-18
2025-12-31	$1,752,032	26,390	-6.3%	Shares	Defined	2026-02-17
2025-09-30	$971,100	28,156	+11.8%	Shares	Defined	2025-11-14
2025-06-30	$398,065	25,194	+372.9%	Shares	Defined	2025-08-13
2025-03-31	$67,865	5,327	-0.6%	Shares	Defined	2025-05-15
2024-12-31	$100,767	5,360	-21.1%	Shares	Defined	2025-02-07
2024-09-30	$131,541	6,791	0.0%	Shares	Defined	2024-11-13
2024-06-30	$176,498	6,791	-75.3%	Shares	Defined	2024-08-14
2023-03-31	$699,719	27,548	-14.3%	Shares	Defined	2023-05-15
2022-12-31	$1,303,679	32,142	-36.2%	Shares	Defined	2023-02-14
2022-09-30	$1,664,497	50,363	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.